JESSICA REYES: Open Payments
NPI 1861044893 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 59 payments from 14 companies in 2025. Trend: 2023 $915 · 2024 $1,491 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $348 |
| Janssen Biotech, Inc. | 8 | $207 |
| Madrigal Pharmaceuticals | 5 | $202 |
| Gilead Sciences, Inc. | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Phathom Pharmaceuticals, Inc. | 4 | $78 |
| Ardelyx, Inc. | 3 | $74 |
| PFIZER INC. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, ENTYVIO, SKYRIZI, VOQUEZNA, IBSRELA, LINZESS.
Industry payments across FL — which companies pay providers there.
